Immunologically active phenotype is associated with response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer
Ontology highlight
ABSTRACT: Immunologically active phenotype is associated with response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer
PROVIDER: PRJNA682139 | ENA |
REPOSITORIES: ENA
ACCESS DATA